STRATEGIC MARKETING INNOVATIONS

Lobbying for CARDINAL POINT PARTNERS, LLC ON BEHALF OF TONIX PHARMACEUTICALS · Federal relations firm

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $10,000.00 income · posted Jan 21, 2026

Lobbying activity 3

Defense

Funding for biodefense and pandemic preparedness medical countermeasures

Health Issues

Funding for biodefense and pandemic preparedness medical countermeasures

Disaster Planning/Emergencies

Funding for biodefense and pandemic preparedness medical countermeasures

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.